                         SEQUENCE LISTING

<110>  Mayo Foundation for Medical Education and Research
 
<120>  METHODS AND MATERIALS FOR TREATING CANCER

<130>  07039-1745WO1

<150>  US 62/613,506
<151>  2018-01-04

<160>  35    

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  DNA
<213>  Homo sapiens

<400>  1
gvagaw                                                                   6


<210>  2
<211>  12
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DNA sequence that transcribes a candidate RNA motif

<400>  2
gaagaagaag at                                                           12


<210>  3
<211>  21
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  shRNA molecule targeting PD-L1

<400>  3
gaccuauaug ugguagagua u                                                 21


<210>  4
<211>  21
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  shRNA molecule targeting PD-L1

<400>  4
cgaauuacug ugaaagucaa u                                                 21


<210>  5
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  nucleic acid encoding an shRNA molecule targeting PD-L1

<400>  5
gacctatatg tggtagagta t                                                 21


<210>  6
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  nucleic acid encoding an shRNA molecule targeting PD-L1

<400>  6
cgaattactg tgaaagtcaa t                                                 21


<210>  7
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  nucleic acid encoding an shRNA molecule targeting HuR

<400>  7
cgtggatcag actacaggtt t                                                 21


<210>  8
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  nucleic acid encoding an shRNA molecule targeting HuR

<400>  8
accatgacaa actatgaaga a                                                 21


<210>  9
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  9
gcaggaggag aaccatacag ac                                                22


<210>  10
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  10
atgatttcgg ctgatcgact                                                   20


<210>  11
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  11
ccaacctgag tcaaacagat ga                                                22


<210>  12
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  12
aagtaatacc atcccccgac tt                                                22


<210>  13
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  13
tgaaagcagt tgagtccaag aa                                                22


<210>  14
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  14
aaagacaact gcggaactca at                                                22


<210>  15
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  15
caatgttaga aaaaggccaa gg                                                22


<210>  16
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  16
gttcacgttt cttcccaatt tc                                                22


<210>  17
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  17
gcggtgattt tcatgactac aa                                                22


<210>  18
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  18
aaatcccatg tatctgcttg ct                                                22


<210>  19
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  19
tgcagtgttc tacaccttgc tt                                                22


<210>  20
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  20
actgaagcca ttttgtttgg at                                                22


<210>  21
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  21
cggagtcaac ggatttggtc gt                                                22


<210>  22
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  22
tctcagcctt gacggtgcca                                                   20


<210>  23
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  23
atggaaggta aagaacctgc aa                                                22


<210>  24
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  24
tggaaggcta ggattgacaa at                                                22


<210>  25
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  25
gacctgcaaa gagcaatgaa g                                                 21


<210>  26
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  26
acccctcttc aactcccact a                                                 21


<210>  27
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  27
gtggtaaaac ccctgggaat                                                   20


<210>  28
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  28
aggatagcac gagctggaaa                                                   20


<210>  29
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  29
tttgcttgag gctgatcctt                                                   20


<210>  30
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer

<400>  30
gattgactct gcagccaaca                                                   20


<210>  31
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide that blocks the PD-L1 binding site for NBS1 RNA

<400>  31

Lys Lys Cys Gly Ile Gln Asp Thr Asn Ser 
1               5                   10  


<210>  32
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  32

Arg Arg Arg Arg Arg Arg Arg Arg 
1               5               


<210>  33
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  33

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Gln 
1               5                   10          


<210>  34
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  34

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  35
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  35

Ile Ala Trp Val Lys Ala Phe Ile Arg Lys Leu Arg Lys Gly Pro Leu 
1               5                   10                  15      


Gly Gly Pro Leu Gly Ile Ala Gly Gln Arg Gly Asp Ser 
            20                  25                  


